Sensing and imaging technology giant Teledyne Technologies Incorporated (NYSE: TDY) has entered into a definitive agreement to acquire Varex Imaging Corporation (NASDAQ: VREX). The all-cash transaction values Varex at approximately $1.1 billion, paying $18.90 per share including Varex’s equity awards and net debt.
The strategic acquisition significantly expands Teledyne’s footprint across global healthcare, oncology, and non-destructive industrial inspection markets.
Transaction Overview & Financial Details
The boards of directors of both companies have unanimously approved the deal.
Teledyne (NYSE: TDY) âž” $18.90/Share Cash Offer âž” Varex Imaging (NASDAQ: VREX) = $1.1B Enterprise Value
| Financial / Strategic Metric | Details |
| Transaction Value | ~$1.1 Billion (inclusive of debt & equity awards) |
| Per Share Price | $18.90 per share in cash |
| Target Sector | X-ray sources, digital detectors, photon counting, & high-voltage components |
| Primary End Markets | Medical diagnostic imaging, oncology, security, & industrial non-destructive testing |
| Expected Closing | Early 2027 (subject to regulatory and shareholder approvals) |
Technological Synergies: Why the Acquisition Makes Sense
While both companies serve OEM manufacturers in similar sectors, Teledyne’s Executive Chairman Robert Mehrabian highlighted that their product portfolios are highly complementary with minimal direct overlap:
- High-Radiation & Oncology Expansion: Teledyne previously produced low-dose CMOS X-ray detectors (via Teledyne DALSA) and magnetrons for radiotherapy (via Teledyne e2v). Varex fills the missing piece by providing detectors specifically engineered for high-radiation oncology environments.
- Advanced Photon Counting: Varex brings cutting-edge photon-counting X-ray detectors to Teledyne, unlocking higher-resolution medical diagnostic imaging and industrial measurement systems.
- X-Ray Tubes & Vacuum Electronics: While Teledyne produces vacuum electronics, it has historically not manufactured X-ray tubes for computed tomography (CT), radiography, or fluoroscopy—a core domain where Varex leads.
Market & Stock Impact
Varex CEO Sunny Sanyal emphasized that the transaction delivers a immediate premium for Varex shareholders while creating a comprehensive global player in medical and industrial imaging hardware.
Following the announcement, shares of both companies saw positive momentum, reflecting market confidence in the long-term cost and technological synergies.
Read – Amnezia VPN Releases Mandatory v5.0.0.5 Upgrade to Counter Censorship and Cyberattacks.